Does early cognitive decline require the presence of both tau and amyloid-β?-Reference-Cited by-同舟云学术

Does early cognitive decline require the presence of both tau and amyloid-β?

Published:2019-12-27 Issue:1 Volume:143 Page:10-13
ISSN:0006-8950
Container-title:Brain
language:en
Short-container-title:

Author:

Schöll Michael¹²³^ORCID,Maass Anne⁴^ORCID

Affiliation:

1. Wallenberg Centre for Molecular and Translational Medicine and the Department of Psychiatry and Neurochemistry, University of Gothenburg, Sweden

2. Dementia Research Centre, Queen Square Institute of Neurology, University College London, UK

3. Clinical Memory Research Unit, Lund University, Sweden

4. German Center for Neurodegenerative Diseases, Magdeburg, Germany

Abstract

This scientific commentary refers to ‘Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age’, by Betthauser et al. (doi: 10.1093/brain/awz378).

Publisher

Oxford University Press (OUP)

Subject

Clinical Neurology

Link

http://academic.oup.com/brain/article-pdf/143/1/10/32298610/awz399.pdf

Reference11 articles.

1. On the path to 2025: understanding the Alzheimer's disease continuum;Aisen;Alzheimers Res Ther,2017

2. Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease;Bell;Alzheimers Dement,2019

3. Primary age-related tauopathy (PART): a common pathology associated with human aging;Crary;Acta Neuropathol,2014

4. PART is part of Alzheimer disease;Duyckaerts;Acta Neuropathol,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotective effects of curculigoside against Alzheimer’s disease via regulation oxidative stress mediated mitochondrial dysfunction in L-Glu-exposed HT22 cells and APP/PS1 mice;Food Science and Human Wellness;2023-07

2. A unique color-coded visualization system with multimodal information fusion and deep learning in a longitudinal study of Alzheimer's disease;Artificial Intelligence in Medicine;2023-06

3. Photodynamic Alzheimer’s disease therapy: From molecular catalysis to photo-nanomedicine;Coordination Chemistry Reviews;2022-11

4. PET Imaging of Tau Pathology and Amyloid-β, and MRI for Alzheimer’s Disease Feature Fusion and Multimodal Classification;Journal of Alzheimer's Disease;2021-12-07

5. Content-specific vulnerability of recent episodic memories in Alzheimer's disease;Neuropsychologia;2021-09